{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:45:33Z","timestamp":1785390333435,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction and hypothesis<\/jats:title>\n                <jats:p>Following the publication of the National Institute for Health and Care Excellence guidelines on the management of pelvic floor dysfunction, articles speculating on the benefits and costs of local and regional multi-disciplinary teams (MDTs) have been in circulation. To date, there has been no formal assessment of the impact of a regional MDT on the management of women with complex urogynaecological conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Throughout the existence of the West of Scotland (WoS) Regional Urogynaecology MDT, from May 2010 to December 2015, 60 patients with complex Urogynaecology conditions were discussed. Data were collected on presenting condition, pre- and post-MDT management plans, and treatment outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The average age was 52.6 years (range 21\u201391 years). All meetings had at least 1 urogynaecologist, 1 gynaecologist, 1 reconstructive female urologists, 1 urodynamicist and, on average, 3 continence nurses, 4 physiotherapists, as well as 1 clinical librarian to conduct a literature search and 1 secretary for administrative support. The majority of the referrals dealt with urinary incontinence (<jats:italic>n<\/jats:italic>=34) and 8 patients presented with mesh complications alongside other pelvic floor disorders. The MDT made changes to the original referrer\u2019s management plan in at least 25 (41.7%) patient presentations. Twenty-two out of all the patients discussed (36.7%) were reported as cured or improved in their condition following the MDT-recommended management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The WoS Regional Urogynaecology MDT had a positive impact on the management of women presenting with complex condition(s). Cross-sharing of resources between hospitals within the region provided a wider range of management plans, better tailored to each individual.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00192-023-05513-5","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T07:02:27Z","timestamp":1681110147000},"page":"2163-2169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of regional multi-disciplinary team on the management of complex urogynaecology conditions"],"prefix":"10.1007","volume":"34","author":[{"given":"Hui Ling","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4836-6581","authenticated-orcid":false,"given":"Wael","family":"Agur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"5513_CR1","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/j.1471-0528.2000.tb11669.x","volume":"107","author":"AH MacLennan","year":"2000","unstructured":"MacLennan AH, Taylor AW, Wilson DH, Wilson D. The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. BJOG. 2000;107:1460\u201370.","journal-title":"BJOG"},{"key":"5513_CR2","unstructured":"Whitfield CR, editor. Dehurst\u2019s textbook of obstetrics and gynaecology for postgraduates. Oxford: Blackwell Science; 1995. p. 642\u201352."},{"issue":"2","key":"5513_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.eururo.2013.04.034","volume":"64","author":"W Agur","year":"2013","unstructured":"Agur W, Riad M, Secco S, et al. Surgical treatment of recurrent stress urinary incontinence in women: a systematic review and meta-analysis of randomised controlled trials. Eur Urol. 2013;64(2):323\u201336.","journal-title":"Eur Urol"},{"key":"5513_CR4","unstructured":"National Institute for Health and Care Excellence (NICE). Urinary incontinence in women. Clinical Guideline. 2013;171"},{"key":"5513_CR5","doi-asserted-by":"crossref","unstructured":"National Institute for Health and Care Excellence (NICE). Urinary incontinence and pelvic organ prolapse in women: management. NICE guideline. 2019;123","DOI":"10.1111\/bju.14763"},{"key":"5513_CR6","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jocn.2010.03.001","volume":"17","author":"KM Field","year":"2010","unstructured":"Field KM, Rosenthal MA, Dimou J, Fleet M, Gibbs P, Drummond K. Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology. J Clin Neurosci. 2010;17:1130\u20135. https:\/\/doi.org\/10.1016\/j.jocn.2010.03.001.","journal-title":"J Clin Neurosci"},{"issue":"9","key":"5513_CR7","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/bjc.2013.586","volume":"109","author":"PB De Ieso","year":"2013","unstructured":"De Ieso PB, Coward JI, Letsa I, et al. A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology. Br J Cancer. 2013;109(9):2295\u2013300.","journal-title":"Br J Cancer"},{"issue":"4","key":"5513_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/01443615.2015.1090415","volume":"36","author":"A Balachandran","year":"2016","unstructured":"Balachandran A, Monga A, Duckett J. Management of female urinary incontinence: a survey of urogynaecologists\u2019 view on the NICE guideline. J Obstet Gynaecol. 2016;36(4):487\u201391. https:\/\/doi.org\/10.3109\/01443615.2015.1090415.","journal-title":"J Obstet Gynaecol"},{"key":"5513_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00192-014-2579-3","volume":"26","author":"A Balachandran","year":"2015","unstructured":"Balachandran A, Duckett J. What is the role of the multidisciplinary team in the management of urinary incontinence? Int Urogynecol J. 2015;26:791.","journal-title":"Int Urogynecol J"},{"key":"5513_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/JMDH.S186847","volume":"12","author":"I Pandeva","year":"2019","unstructured":"Pandeva I, Biers S, Pradhan A, Verma V, Slack M, Thiruchelvam N. The impact of pelvic floor multidisciplinary team on patient management: the experience of a tertiary unit. J Multidiscip Healthc. 2019;12:205\u201310.","journal-title":"J Multidiscip Healthc"},{"key":"5513_CR11","unstructured":"NHS England Commissioning Group. MDT Development\u2014working toward an effective multidisciplinary\/multiagency team. 2014."},{"key":"5513_CR12","unstructured":"NHS England. Specialised complex surgery for urinary incontinence and vaginal and uterine prolapse (16 years and above). 2020. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2020\/02\/1649-urinary-incontinence-vaginal-uterine-prolapse-service-specification-.pdf"},{"key":"5513_CR13","unstructured":"First Do No Harm. The report of the Independent Medicines and Medical Devices Safety Review. 2020."}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-023-05513-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-023-05513-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-023-05513-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T14:03:32Z","timestamp":1695045812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-023-05513-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5513"],"URL":"https:\/\/doi.org\/10.1007\/s00192-023-05513-5","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"16 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Wael Agur has received trainer and speaker fees from CR Bard for training surgeons on mesh procedures for incontinence and prolapse, sponsorship from Boston Scientific for training on mesh procedures for prolapse, sponsorship from Neomedic for training on mesh procedures for incontinence, trainer and speaker fees from Contura\/SEP Pharma, NHS Ayrshire and Arran, and the London Medical Education Academy, for training surgeons on non-mesh continence procedures; expert fees from NHS Scotland and various law firms in Scotland, England, USA and Australia for the provision of medico-legal advice, expert report writing and\/or appearance in court, on mesh litigation; and institutional research support as principal investigator for the SIMS Pilot, PROSPECT, VUE and PURSUIT studies. Wael Agur was also a member of an All-Party Parliamentary Group on surgical mesh.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclaimers\/conflicts of interest"}}]}}